PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target EGF 27,487 5 0.00 -0.99 0.02 0.60
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Prostate Cancer 71,064 6 0.00 -0.99 0.03 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target ERK1 18,374 8 0.00 -0.98 0.03 0.63
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Carcinoma 433,099 11 0.00 -0.98 0.05 0.55
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Breast Cancer 173,695 13 0.00 -0.97 0.06 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Cancer 1,053,491 55 0.00 -0.87 0.24 0.57
4-1BB Ligand 135 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Target Collagen 138,882 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Disease Arthritis 128,324 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
4-1BB Ligand 135 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.01 0.55
4-1BB Ligand 135 Target Disease Sepsis 64,798 1 0.00 -1.00 0.01 0.55
4-1BB Ligand 135 Target Drug Doxorubicin 28,033 1 0.00 -1.00 0.01 0.57
4-1BB Ligand 135 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.01 0.57
4-1BB Ligand 135 Target Disease Leukemias 14,152 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Myelodysplastic Syndrome 7,378 1 0.00 -1.00 0.01 0.60
4-1BB Ligand 135 Target Target CCL3 1,427 1 0.00 -1.00 0.01 0.65
4-1BB Ligand 135 Target Target BTK 1,263 1 0.00 -1.00 0.01 0.65